Newsfeeds - Spark Newswire

1 minute read

Analyst Ratings
Cannabis
Downgrades
Markets
News
Price Target

Canaccord Genuity Downgrades Greenbrook TMS to Speculative Buy, Lowers Price Target to C$7.5

Today, 10:57 PM

Canaccord Genuity analyst Tania Gonsalves downgrades Greenbrook TMS (TSX:GTMS) from Buy to Speculative Buy and lowers the price target from C$18.5 to C$7.5.

TSX:GTMS

3 minute read

M&A
News
Offerings

Greenbrook TMS To Acquire Achieve TMS East And Central, Announces $10M Bought Deal Public Offering

By Benzinga Newsdesk

Today, 10:57 PM

Greenbrook TMS Inc. (TSX:GTMS) (NASDAQ:GBNH) ("Greenbrook" or the "Company"), a leading provider of Transcranial Magnetic Stimulation ("TMS") therapy in the United States, announced today

GBNH